Pixel Perfect
Therapeutics

Driving faster and smarter drug product decisions with microstructure science

digiM delivers advanced 3D microstructure intelligence that predicts product quality and performance, accelerates pharmaceutical development, and de‑risks regulatory approval.
AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo
AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo

Our Expertise

In Numbers

95
+
%

Programs Supported

981
+
%

Formulations Digitized

22
+
%

Pharmaceutical Partners

Stats section background image for DigiM Solution website showing pharmaceutical data visualization context

Microstructure Imaging

digiM correlative microscopy creates permanent, reusable digital twins that turn microstructure insight into competitive advantage.

Microstructure Quantification

Using proprietary AI image analysis and automation, digiM quantifies microstructure attributes as strategic quality levers, that enhances CQAs, links to CPPs, and accelerates development decisions with increased confidence.

Microstructure Performance Prediction

digiM microstructure-faithful predictions use real-world 3D structures, mechanistic models, and generative AI structure synthesis to digitally optimize formulation and process, vastly reducing experiments, time, costs, and risks.

digiM and the FDA

digiM team partners with regulatory agencies to develop regulatory guidelines, validate scientific methodology, and support regulatory science research via grants and software subscriptions. digiM supports clients in all filing types and stages.

Upscaled FIB-SEM image 2 of a pharmaceutical tablet at 25 µm scale showing secondary microstructure region
Upscaled FIB-SEM image 4 of a pharmaceutical sample showing cross-sectional material phases at nanoscale resolution
Applications

Products We Support

Our solutions are designed to solve hurdles for every stage of product development, across nearly all dosage forms and therapeutic modalities.

Transform Your Program with Microstructure Science

Get started with a drug product digital twin.

A purple tablet dissolving